| Financial Year |
March 31 2023 |
| Monetary Funds |
515,850,737.83 |
| Held-for-trading Financial Assets |
35,003,382.64 |
| Notes Receivable |
2,745,145.42 |
| Accounts Receivable |
89,787,442.65 |
| Advances to Suppliers |
10,882,346.91 |
| Other Receivables |
415,944,425.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
78,533,333.33 |
| Dividend Receivable |
-- |
| Inventories |
639,960,363.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
37,256,848.92 |
| Other Current Assets |
23,204,936.43 |
| Total Current Assets |
1,771,922,816.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
32,868,036.99 |
| Long-term Equity Investment |
349,482,036.42 |
| Investment Properties |
249,682,847.98 |
| Fixed Assetes |
562,922,214.28 |
| Under-construction Projects |
19,906,270.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,285,345.97 |
| R&D expenses |
-- |
| Goodwill |
111,614,451.03 |
| Long-Term Deferred and Prepaid Expenses |
224,245,133.28 |
| Deferred Income Tax Assets |
6,372,967.73 |
| Other Non-Current Assets |
2,749,800.00 |
| Sub-Total of Non-Current Assets |
1,868,162,576.16 |
| Total Assets |
3,640,085,392.25 |
| Short-Term Loans |
1,751,393.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
92,813,335.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,482,012.98 |
| Taxes Payable |
114,064,945.64 |
| Interest Payable |
-- |
| Dividend Payable |
3,285,533.94 |
| Other payables |
86,705,972.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,406,993.88 |
| Other Current Liabilities |
6,980,240.87 |
| Sub-Total of Current Liabilities |
410,282,021.67 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
329,667.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
46,453,822.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
315,060,856.00 |
| Total Liabilities |
725,342,877.67 |
| Paid-In Capital(Or Share Stock) |
1,992,869,681.00 |
| Capital Surplus |
3,001,946,868.82 |
| Surplus Reserve |
101,374,259.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,328,877,546.90 |
| Minority Stockholder's Interest |
144,915,229.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,769,827,285.52 |
| Owner's Equity（Stockholder's Equity） |
2,914,742,514.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,640,085,392.25 |
